Baseline levels, and changes over time in body mass index and fasting insulin, and their relationship to change in metabolic trait clustering

Metabolic Syndrome and Related Disorders

Volumn 12, Issue 7, 2014, Pages 372-380

  Rutter, Martin K ^a   Sullivan, Lisa M ^b   Fox, Caroline S ^c,d,e   Wilson, Peter W F ^f   Nathan, David M ^c,g   Vasan, Ramachandran S ^d,h   D'Agostino, Ralph B ^b   Meigs, James B ^c,g  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b BOSTON UNIVERSITY   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d FRAMINGHAM HEART STUDY   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g MASSACHUSETTS GENERAL HOSPITAL   (United States)

^h BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; METABOLISM; OBESITY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; TIME; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; BLOOD; CLUSTER ANALYSIS; COMPLICATION; MIDDLE AGED; PHYSIOLOGY; RISK FACTOR;

ADIPOSITY; ADULT; BODY MASS INDEX; CLUSTER ANALYSIS; FASTING; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; RISK FACTORS; TIME FACTORS;

EID: 84906704584     PISSN: 15404196     EISSN: 15578518     Source Type: Journal    
DOI: 10.1089/met.2013.0148     Document Type: Article

References (48)

1. Wilson PW, Kannel WB, Silbershatz H, et al. Clustering of metabolic factors and coronary heart disease. Arch Intern Med 1999;159:1104-1109.
2. Ford ES. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care 2005;28:2745-2749.
3. Hanley AJ, Karter AJ, Williams K, et al. Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome: The Insulin Resistance Atherosclerosis Study. Circulation 2005;112:3713-3721.
4. Mottillo S, Filion KB, Genest J, et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol 2010;56:1113-1132.
5. Han TS, Williams K, Sattar N, et al. Analysis of obesity and hyperinsulinemia in the development of metabolic syndrome: San Antonio Heart Study. Obes Res 2002;10:923-931.
6. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37:1595-1607.
7. Ferrannini E, Haffner SM, Mitchell BD, et al. Hyperinsulinaemia: The key feature of a cardiovascular and metabolic syndrome. Diabetologia 1991;34:416-422.
8. Schmidt MI, Watson RL, Duncan BB, et al. Clustering of dyslipidemia, hyperuricemia, diabetes, and hypertension and its association with fasting insulin and central and overall obesity in a general population. Atherosclerosis Risk in Communities Study Investigators. Metabolism 1996;45:699-706.
9. Schmidt MI, Duncan BB, Watson RL, et al. A metabolic syndrome in whites and African-Americans. The Atherosclerosis Risk in Communities baseline study. Diabetes Care 1996;19:414-418.
10. Meigs JB, DAgostino RB, Sr, Wilson PW, et al. Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study. Diabetes 1997;46:1594-1600.
11. Janssen I, Katzmarzyk PT, Ross R.Body mass index, waist circumference, and health risk: Evidence in support of current National Institutes of Health guidelines. Arch Intern Med 2002;162:2074-2079.
12. Lin WY, Yang WS, Lee LT, et al. Insulin resistance, obesity, and metabolic syndrome among non-diabetic preand post-menopausal women in North Taiwan. Int J Obes (Lond) 2006;30:912-917.
13. Ferrannini E, Balkau B, Coppack S., et al. Insulin resistance, insulin response, and obesity as indicators of metabolic risk. J Clin Endocrinol Metab 2007;92:2885-2892.
14. Oka R, Kobayashi J, Inazu A, et al. Contribution of visceral adiposity and insulin resistance to metabolic risk factors in Japanese men. Metabolism 2010;59:748-754.
15. Mykkanen L, Haffner SM, Ronnemaa T, et al. Low insulin sensitivity is associated with clustering of cardiovascular disease risk factors. Am J Epidemiol 1997;146:315-321.
16. Park SH, Lee WY, Rhee EJ, et al. The relative risks of metabolic syndrome according to the degree of insulin resistance in apparently healthy Korean adults. Clin Sci (Lond) 2005;108:553-559.
17. Liese AD, Mayer-Davis EJ, Tyroler HA, et al. Development of the multiple metabolic syndrome in the ARIC cohort: Joint contribution of insulin, BMI, and WHR. Atherosclerosis Risk in Communities. Ann Epidemiol 1997; 7:407-416.
18. Everson SA, Goldberg DE, Helmrich SP, et al. Weight gain and the risk of developing insulin resistance syndrome. Diabetes Care 1998;21:1637-1643.
19. Srinivasan SR, Myers L, Berenson GS. Predictability of childhood adiposity and insulin for developing insulin resistance syndrome (syndrome X) in young adulthood: The Bogalusa Heart Study. Diabetes 2002;51:204-209.
20. Palaniappan L, Carnethon MR, Wang Y, et al. Predictors of the incident metabolic syndrome in adults: The Insulin Resistance Atherosclerosis Study. Diabetes Care 2004;27: 788-793.
21. Chen W, Srinivasan SR, Li S, Xu J, et al. Clustering of long-term trends in metabolic syndrome variables from childhood to adulthood in Blacks and Whites: The Bogalusa Heart Study. Am J Epidemiol 2007;166:527-533.
22. Mirmiran P, Noori N, Azizi F. A prospective study of determinants of the metabolic syndrome in adults. Nutr Metab Cardiovasc Dis 2008;18:567-573.
23. Cameron AJ, Boyko EJ, Sicree RA, et al.Central obesity as a precursor to the metabolic syndrome in the AusDiab study and Mauritius. Obesity (Silver Spring) 2008;16:2707-2716.
24. Haffner SM, Valdez RA, Hazuda HP, et al. Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes 1992;41:715-722.
25. Srinivasan SR, Myers L, Berenson GS. Rate of change in adiposity and its relationship to concomitant changes in cardiovascular risk variables among biracial (black-white) children and young adults: The Bogalusa Heart Study. Metabolism 2001;50:299-305.
26. Case CC, Jones PH, Nelson K, et al. Impact of weight loss on the metabolic syndrome. Diabetes Obes Metab 2002; 4:407-414.
27. Hillier TA, Fagot-Campagna A, Eschwege E, et al. Weight change and changes in the metabolic syndrome as the French population moves towards overweight: The D.E.S.I.R. cohort. Int J Epidemiol 2006;35:190-196.
28. Garnett SP, Baur LA, Srinivasan S, et al. Body mass index and waist circumference in midchildhood and adverse cardiovascular disease risk clustering in adolescence. Am J Clin Nutr 2007;86:549-555.
29. Maison P, Byrne CD, Hales CN, et al. Do different dimensions of the metabolic syndrome change together over time? Evidence supporting obesity as the central feature. Diabetes Care 2001;24:1758-1763.
30. Sung KC, Seo MH, Rhee EJ, et al. Elevated fasting insulin predicts the future incidence of metabolic syndrome: A 5-year follow-up study. Cardiovasc Diabetol 2011;10:108.
31. Kannel WB, Feinleib M, McNamara PM, et al. An investigation of coronary heart disease in families. The Framingham offspring study. Am J Epidemiol 1979;110: 281-290.
32. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the Metabolic Syndrome. A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640-1645.
33. Meigs JB, Mittleman MA, Nathan DM, et al. Hyperinsulinemia, hyperglycemia, and impaired hemostasis: The Framingham Offspring Study. JAMA 2000;283:221-228.
34. World Health Organization. The World Health Report: Conquering Suffering, Enriching Humanity. Geneva: World Health Organization; 1997.
35. Laakso M. How good a marker is insulin level for insulin resistance? Am J Epidemiol 1993;137:959-965.
36. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
37. Bonora E, Targher G, Alberiche M, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: Studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000;23:57-63.
38. Levy JC, Matthews DR, Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 1998;21:2191-2192.
39. Hotamisligil GS, Spiegelman BM.Tumor necrosis factor alpha: A key component of the obesity-diabetes link. Diabetes 1994;43:1271-1278.
40. Adiels M, Olofsson SO, Taskinen MR, et al. Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome. Arterioscler Thromb Vasc Biol 2008;28:1225-1236.
41. Hall JE, Brands MW, Henegar JR. Mechanisms of hypertension and kidney disease in obesity. Ann NY Acad Sci 18 1999;892:91-107.
42. Semplicini A, Ceolotto G, Massimino M, et al. Interactions between insulin and sodium homeostasis in essential hypertension. Am J Med Sci 1994;307(Suppl 1): S43-S6.
43. Kern W, Peters A, Born J, et al. Changes in blood pressure and plasma catecholamine levels during prolonged hyperinsulinemia. Metabolism 2005;54:391-396.
44. DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991;14:173-194.
45. Gale EA. The myth of the metabolic syndrome. Diabetologia 2005;48:1679-1683.
46. Kahn R, Buse J, Ferrannini E, et al. The metabolic syndrome: Time for a critical appraisal Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 2005;48:1684-1699.
47. Yudkin JS. Insulin resistance and the metabolic syndrome- or the pitfalls of epidemiology. Diabetologia 2007;50: 1576-1586.
48. Shoelson SE, Herrero L, Naaz A. Obesity, inflammation, and insulin resistance. Gastroenterology 2007;132:2169-2180.